Tagged with

cancer Eduardo Payet of INEN outlines the institution’s agenda for preventing advanced stages of cancer and plans to expand oncology services beyond Lima to more remote regions of Peru. What is your assessment of the state of cancer in Peru today? Peru is experiencing a demographic and epidemiological transition as a…

MSD Guillermo Browne, Managing Director of MSD Peru, talks about the turnover of the affiliate and the company’s success in bringing new innovation to the country, particularly in the areas of vaccines and oncology. You arrived in Peru in January 2014. What initial tasks did you set for yourself? When I arrived, MSD…

oncology Despite Peru’s sometimes-sluggish development when it comes to healthcare, the progression of cancer prevention and control in recent decades is tremendous. This is particularly important as the number of cancer cases increases by 50,000 annually in Peru. Communicable diseases like infectious diseases, which used to be a predominant cause of death…

access The president of Turkey’s social security institution, the SGK, discusses the evolution of healthcare spending over the past three years, and the underpinning principles guiding their drug reimbursement policy decisions. Since 2012, medical expenses have been increasing; can you please analyze the situation? Since 2006, the ‘Sosyal Güvenlik Kurumu’ (SGK),…

exports The chairman and general manager of Bottu discuss their flagship product, Doliprane, the potential for export to the rest of Africa, and partnerships with European labs. Bottu is a Moroccan laboratory and is a little over sixty years old. The company experienced a dramatic acceleration in business a few years…

export The CEO of one of Morocco’s largest pharma companies discusses investment in production capacity, and the potential to export products to French and English-speaking Africa.    Can you introduce Pharma 5 and its organization in a few words? The Pharma 5 group, a Moroccan pioneer in generic drug development and…

manufacturing The director general of Cooper Pharma explains how the company has become the leading Moroccan player, why Morocco´s relationship with Africa is one of cooperation not exploitation, and how the country now needs to look towards innovation if it is to compete.   Cooper Pharma celebrated its 80th anniversary in…

pricing The president and chairman of MC Pharma discusses the position of the pharmacy segment in the current Moroccan healthcare context.  Could you introduce MC Pharma to our international readers, and more especially describe the relationship that exists between MC Pharma and Cooper Pharma? MC Pharma was established in 2002 by…

medical devices seca is turning ten years old in Mexico in 2015. The general director of the Mexico affiliate discusses how the company foresaw the growing demand for medical measuring systems and scales in the country due to an increasingly overweight population and how the company is helping doctors foster prevention.  …

government ‘Poverty is fought with health, education and, above all, employment and more employment’. This is the vision Carlos Slim has for Mexico. The CEO of the Carlos Slim Foundation discusses how the foundation is actively involved in shaking up the system to bring innovation – and energy – to health.…

medical devices The general manager for Mexico, Central America and Caribbean shares his point of view about the announced healthcare reform, the opportunities and challenges it presents and how BD is adapting to an ever-changing landscape.     It seems that the next item on the government’s agenda is healthcare reform. How…

R&D “When I left Janssen, I never imagined joining a Korean company,” recalls Choi Tae-Hung, sipping a freshly brewed yujacha tea in his office on a crisp autumn morning as he gazes down at the busy, sundrenched streets of Seoul below. “I thought that the global business of Korean pharmaceutical companies…